The report of the World Health Organization (WHO), based on data from 77 countries, indicates the rapidly growing resistance of gonorrhea to modern antibacterial drugs, according to the Internet publication for girls and women aged 14 to 35 Pannochka. net In a number of cases, antibiotic resistance makes the infection of Neisseria gonorrhoeae difficult to cure or almost incurable.

"The bacterium that causes gonorrhea adapts rather quickly. Each appointment of new antibiotics becomes for her a new experience leading to the development of resistance, "explains Dr. Teodora Wi from WHO.

According to the report, Neisseria gonorrhoeae is resistant to old cheap antibiotics. In developed countries, strains are increasingly encountered, which are almost impossible to kill with traditional drugs. According to Dr. Wi, these episodes are only the tip of the iceberg, since the system for diagnosing and collecting messages about resistant infections in the third world is almost not developed. There, these cases simply do not analyze.

According to rough estimates by WHO, about 78 million cases of gonococcal infection are registered annually on the planet. Neisseria gonorrhoeae affects the reproductive tract, rectum, throat.

Inflammatory diseases of the pelvic organs in women, ectopic pregnancy, tubal infertility, increased risk of HIV infection - this is only an incomplete list of the consequences of gonorrhea.

Factors that contribute to the spread of gonorrhea are disregard for condoms, urbanization and travel, poor diagnosis and inadequate treatment of infection in many parts of the world.

Than to treat a gonorrhea today?.

In the framework of the WHO GASP program, experts documented the resistance of gonorrhea to ciprofloxacin in 97% of the countries of the world (2009-2014).

According to other data, resistance to azithromycin has increased by 81%, and to 66% to cephalosporins with a wide activity spectrum (such as oral cefixime or ceftriaxone).

Currently, in most countries, drugs of choice in gonorrhea remain cephalosporins with a wide range of activities. In more than 50 countries, the resistance of Neisseria gonorrhoeae to cefixime has been fixed, ceftriaxone slightly slows down.

Due to these changes, the updated recommendations of the WHO 2016 on the therapy of gonococcal infection offer specialists to prescribe simultaneously two drugs (ceftriaxone + azithromycin).

At present, pharmaceutical corporations are working on three new antibiotics. However, they are all at different stages of clinical trials, and tomorrow they will not hit the shelves of our pharmacies.

It's hard to say how the situation will develop further. It remains to hope for such tools as informing people, effective prevention, timely diagnosis and a system for recording the resistance of bacteria.

medbe. en.